ProfileGDS5678 / 1418004_a_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 99% 99% 99% 99% 99% 99% 99% 99% 99% 98% 98% 99% 99% 98% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 110.75699
GSM967853U87-EV human glioblastoma xenograft - Control 210.761799
GSM967854U87-EV human glioblastoma xenograft - Control 310.800499
GSM967855U87-EV human glioblastoma xenograft - Control 411.170799
GSM967856U87-EV human glioblastoma xenograft - Control 510.783799
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 111.344699
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 211.144299
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 311.229199
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 411.332599
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 110.387198
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 210.525398
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 310.758299
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 410.863199
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 510.643198